Article
Losartan hydroxylation phenotype in an Ecuadorian population: influence of CYP2C9 genetic polymorphism, habits and gender.
Pharmacogenomics - 1 Nov 2012
Dorado Pedro, Beltrán Leonardo J, Machín Esther, Peñas-Lledó Eva M, Terán Enrique, Llerena Adrián
Abstract excerpt
AIM: To describe for the first time CYP2C9 hydroxylation phenotype with CYP2C9 genotypes in a Hispanic (Ecuadorian) population using losartan; and the relevance of gender, tobacco, ethanol and caffeine consumption on the enzyme hydroxylation capacity. METHODS: Ecuadorian healthy volunteers (n = 194) received a single oral dose of 25 mg losartan. Losartan metabolic ratio was defined as losartan:E3174...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
